GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma

$1,178,126
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Center for Advanced Multi-Omic Characterization of Cancer

$1,178,071
Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2024 · CA

1/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership

$1,178,009
Brian M. Rivers · Morehouse School Of Medicine · U54 · FY2021 · CA

Metabolic regulation of T cell effector function and anti-tumor immunotherapy

$1,177,923
Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Stanford O'Brien Urology Research Center

$1,177,081
James D Brooks · Stanford University · U54 · FY2025 · DK

The Houston Center for Acquired Resistance Research (H-CARR)

$1,174,728
Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA

Cancer cell adaptation to metabolic stress

$1,173,280
M. Celeste Simon · University Of Pennsylvania · P01 · FY2014 · CA

The Houston Center for Acquired Resistance Research (H-CARR)

$1,172,214
Jeffrey Nicholas Myers · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA

Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer

$1,171,708
James S Duncan · Yale University · R01 · FY2025 · CA

Discovery of Tumor, Treatment Response, and Systems-based EVP Signatures

$1,170,572
Jennifer Jones · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center

$1,170,059
Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2024 · CA

Molecular Pathology of Pulmonary Carcinogenesis

$1,169,604
Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia

$1,168,038
Jeffrey Wallace Tyner · Oregon Health & Science University · U01 · FY2025 · CA

Vermont PROSPR Research Center (VPRC)

$1,167,472
Brian L Sprague · University Of Vermont & St Agric College · U54 · FY2014 · CA

Center for Electron Paramagnetic Resonance Imaging in Vivo Physiology

$1,167,203
Howard J Halpern · University Of Chicago · P41 · FY2014 · EB

Vermont Breast Cancer Molecular Characterization Laboratory

$1,167,066
Janet L Stein · University Of Vermont & St Agric College · U01 · FY2019 · CA

Function Of Skeletal Matrix Genes

$1,166,147
Marian F Young · National Institute Of Dental & Craniofacial Research · ZIA · FY2012 · DE

Cancer Prevention-Interception Against MGUS Progression

$1,166,056
Yong Li · Baylor College Of Medicine · U54 · FY2023 · CA

Dynamic State Space Modeling of Cancer Cell Response to Therapy

$1,164,374
Garry P Nolan · University Of Southern California · U54 · FY2012 · CA

NF Center: from animal models to therapeutics

$1,163,738
Luis F Parada · Ut Southwestern Medical Center · P50 · FY2010 · NS

THE ROLE OF HYPOXIA IN THE TUMOR MICROENVIRONMENT: IMPLICATIONS FOR OVARIAN CANCER THERAPY

$1,163,732
The Leland Stanford Junior University · · FY2015 · Department of the Army

MOLECULAR ONCOLOGY PROGRAM PROJECT

$1,163,442
University Of South Florida · P01 · FY2002 · CA

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,163,016
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Development and Translation of D-glucose as a Diagnostic Agent for MRI of Cancer

$1,163,005
Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2015 · EB

UCLA SPORE in Prostate Cancer

$1,162,609
Robert E Reiter · University Of California Los Angeles · P50 · FY2018 · CA